Suppr超能文献

了解埃塞俄比亚和坦桑尼亚的 COVID-19 疫苗接种、接受和犹豫情况:范围综述。

Understanding the COVID-19 vaccine uptake, acceptance, and hesitancy in Ethiopia and Tanzania: a scoping review.

机构信息

Institute of Health, Jimma University, Jimma, Ethiopia.

Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.

出版信息

Front Public Health. 2024 Nov 11;12:1422673. doi: 10.3389/fpubh.2024.1422673. eCollection 2024.

Abstract

BACKGROUND

The development and implementation of COVID-19 vaccines have been a breakthrough in controlling the pandemic. However, the vaccination coverage in most low-income countries remains very low due to critical vaccine shortage and profound hesitancy. In this scoping review, we aimed to assess COVID-19 vaccine uptake, acceptance, and hesitancy in Ethiopia and Tanzania.

METHODS

The search was made in PubMed, Scopus, Embase, and Web of Science. Only original research articles focusing on vaccine acceptance and hesitancy were included. The studies selected for a full read were analysed using a thematic analysis approach.

FINDINGS

A total of 76 articles were included in the study, with 74 of them coming from Ethiopia. The study found an increasing trend in vaccine uptake over time. However, there was also an increase in hesitancy and a decline in willingness to receive the vaccine. The willingness to receive the COVID-19 vaccine in Ethiopia ranged from 18.5 to 88%. The main reasons for "vaccine hesitancy" included fear of side effects, concerns about long-term safety, doubts about vaccine effectiveness, lack of information, vaccine fast-tracking, and religious beliefs. The study also found that younger individuals, females, and pregnant women were less willing to receive the vaccine. The adverse events reported among vaccinated individuals were mostly mild. Most of the studies operationalised vaccine acceptance-hesitancy as dichotomous variables. However, the historical, political, and socio-cultural context in which vaccine acceptance and hesitancy occur was not given any attention. While there is a good amount of data from Ethiopia describing patterns of vaccine acceptance and hesitancy among different populations over time, there is limited information from Tanzania due to the late arrival of the vaccine and limited published articles.

CONCLUSION

We have observed a paradox involving two seemingly conflicting trends: an increase in vaccination rates/coverage and "anti-vax." Most studies have simplified vaccine acceptance-hesitancy as an "either-or" incident, without considering its dynamic nature and occurrence within a broader political, social, and cultural context. Therefore, it is crucial to explore approaches that can enhance our understanding of the vaccine acceptance-hesitancy phenomenon, in order to improve vaccine trust and uptake.

摘要

背景

新冠疫苗的研发和应用是控制大流行的一项突破。然而,由于疫苗严重短缺和强烈的犹豫,大多数低收入国家的疫苗接种覆盖率仍然非常低。在本次范围综述中,我们旨在评估埃塞俄比亚和坦桑尼亚的新冠疫苗接种、接受和犹豫情况。

方法

在 PubMed、Scopus、Embase 和 Web of Science 中进行了检索。仅纳入关注疫苗接受和犹豫的原始研究文章。对进行全文阅读的研究使用主题分析方法进行分析。

结果

共有 76 篇文章纳入研究,其中 74 篇来自埃塞俄比亚。研究发现,随着时间的推移,疫苗接种率呈上升趋势。然而,犹豫情绪也在增加,愿意接种疫苗的意愿在下降。埃塞俄比亚的 COVID-19 疫苗接种意愿率在 18.5%至 88%之间。“疫苗犹豫”的主要原因包括对副作用的恐惧、对长期安全性的担忧、对疫苗有效性的怀疑、缺乏信息、疫苗快速追踪以及宗教信仰。研究还发现,年轻个体、女性和孕妇不太愿意接种疫苗。接种疫苗者报告的不良事件大多较轻。大多数研究将疫苗接受-犹豫操作化为二分类变量。然而,疫苗接受和犹豫发生的历史、政治和社会文化背景并没有得到任何关注。尽管埃塞俄比亚有大量数据描述了不同人群随时间推移的疫苗接受和犹豫模式,但由于疫苗的到来较晚和发表的文章有限,坦桑尼亚的信息有限。

结论

我们观察到一个矛盾现象,即接种率/覆盖率增加和“反疫苗”同时存在。大多数研究将疫苗接受-犹豫简化为“非此即彼”的事件,而没有考虑其动态性质及其在更广泛的政治、社会和文化背景下的发生情况。因此,探索能够增强我们对疫苗接受-犹豫现象的理解的方法至关重要,以提高疫苗信任度和接种率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844a/11586356/566d4f05e229/fpubh-12-1422673-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验